BDX and IIQ are making incredibly similar claims in terms of specificity, sensitivity, accuracy
Both are blood tests - but operate around different molecules
BDX currently focused on breast cancer only - but hinting at other tests
IIQ looks like its 1 year ahead in terms of launch a lab test - IIQ Dec '23 / BDX Dec '24
BDX MC = $24.3 mill
IIQ MC = $57 mill
Anybody got a view on how to compare them? Who has the better chance to succeed?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.020(5.26%) |
Mkt cap ! $44.65M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 40.0¢ | 38.5¢ | $20.93K | 53.10K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10458 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 18/09/2025 (20 minute delay) ? |
| IIQ (ASX) Chart |